Hester Biosciences has informed that the meeting of the Board of Directors of the Company is scheduled on 31/07/2019 to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended on 30 June 2019.
The above information is a part of company’s filings submitted to BSE.